Results 11 to 20 of about 347,544 (289)
Identification of microRNAs for the early diagnosis of Parkinson’s disease and multiple system atrophy [PDF]
MicroRNAs are reportedly involved in the pathogenesis of neurodegenerative diseases, including Parkinson’s disease and multiple system atrophy. We previously identified 7 differentially expressed microRNAs in Parkinson’s disease patients and control sera
Jia-Hui Yan, Ping Hua, Yong Chen, Lan-Ting Li, Cui-Yu Yu, Lei Yan, Hui Zhang, Ying He, Hao Zheng, Hui Chen, Zhao-Jing Zhang, Qi-Hui Yao, Hui Dong, Wei-Guo Liu
doaj +1 more source
Gustatory rhinitis in multiple system atrophy
Gustatory rhinitis is a type of nonallergic, noninflammatory rhinitis. A high incidence of rhinorrhea, including gustatory rhinitis, is reported in patients with Parkinson’s disease (PD). Herein, we report a case of gustatory rhinitis in a patient with a
Kaoru Yamakawa +5 more
doaj +1 more source
Multiple system atrophy (MSA) is a sporadic, adult-onset, relentlessly progressive neurodegenerative disorder, clinically characterized by various combinations of autonomic failure, parkinsonism and ataxia. The neuropathological hallmark of MSA are glial cytoplasmic inclusions consisting of misfolded α-synuclein.
Fanciulli, Alessandra +5 more
openaire +4 more sources
Freezing of Gait in Multiple System Atrophy
Background and PurposeFreezing of gait (FOG) is a common gait disturbance phenomenon in multiple system atrophy (MSA) patients. The current investigation assessed the incidence FOG in a cross-sectional clinical study, and clinical correlations associated
Huaguang Yang +10 more
doaj +1 more source
Cognitive performance in multiple system atrophy [PDF]
The cognitive performance of a group of patients with multiple system atrophy (MSA) of striato-nigral predominance was compared with that of age and IQ matched control subjects, using three tests sensitive to frontal lobe dysfunction and a battery ...
James, M. +5 more
core +1 more source
Multiple system atrophy - a clinicopathological update
Multiple system atrophy (MSA) is a fatal, adult-onset neurodegenerative disorder of uncertain etiology, clinically characterized by various combinations of Levo-dopa-unresponsive parkinsonism, and cerebellar, motor, and autonomic dysfunctions.
Kurt A. Jellinger
doaj +1 more source
Heterogeneity of Multiple System Atrophy: An Update
Multiple system atrophy (MSA) is a fatal, rapidly progressing neurodegenerative disease of uncertain etiology, clinically characterized by various combinations of Levodopa unresponsive parkinsonism, cerebellar, autonomic and motor dysfunctions.
Kurt A. Jellinger
doaj +1 more source
Benzodiazepine receptor binding in cerebellar degenerations studied with positron emission tomography [PDF]
We used positron emission tomography with [ 11 C]flumazenil to study gamma‐aminobutyric acid type A/benzodiazepine receptor binding quantitatively in the cerebral hemispheres, basal ganglia, thalamus, cerebellum, and brainstem of 72 subjects, including ...
Albin +61 more
core +1 more source
The genetic basis of multiple system atrophy
Multiple system atrophy (MSA) is a heterogenous, uniformly fatal neurodegenerative ɑ-synucleinopathy. Patients present with varying degrees of dysautonomia, parkinsonism, cerebellar dysfunction, and corticospinal degeneration.
Fan Shuen Tseng +3 more
doaj +1 more source
Clinical characteristics of multiple system atrophy in Serbian population [PDF]
Background/Aim. Mulstiple system atrophy (MSA) is a neurodegenerative central nervous system disorder, characterized by any combination of extrapyramidal, cerebellar, pyramidal or autonomic disturbance.
Dragašević Nataša +5 more
core +1 more source

